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Abstract The present paper reveals that a fluorescent derivative
of nitrobenzylthioinosine, 5-(SAENTA-x8)-fluorescein, is a
highly specific inhibitor of the neural NBTI-sensitive nucleoside
transporter. 5-(SAENTA-x8)-fluorescein inhibited adenosine
transport and [3H]NBTI binding with a Ki of 4 nM in cultured
chromaffin cells. Flow cytometry demonstrated that 5-(SAEN-
TA-x8)-fluorescein specifically interacted with the NBTI-sensi-
tive nucleoside transporters with high affinity (KD = 6 nM).
Activation of protein kinases A and C with forskolin or nicotinic
receptor agonists, respectively, resulted in 50% inhibition of the
fluorescence bound to the cells. Flow cytometry will allow
studying nucleoside transport in single cells from heterogeneous
neural cell populations.
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1. Introduction
The equilibrative nucleoside transporters widely distributed
in mammalian tissues are responsible for the internalization of
nucleosides, preferentially adenosine, ¢nishing the extracellu-
lar actions [1,2]. The quantifying and localization of nucleo-
side transporters as other plasma membrane proteins (trans-
porters or receptors) have been restricted by the use of
binding techniques with radiolabelled speci¢c ligands, such
as [3H]dipyridamol and [3H]nitrobenzylthioinosine (NBTI),
which require a large number of cells [3^5]. This is not the
case for the nucleoside transporters that have been cloned,
and speci¢c molecular probes are available [6]. An interesting
development in the ¢eld of equilibrative nucleoside transport-
ers has been the synthesis of £uorescent ligands. These com-
pounds result from the coupling of a £uorescein molecule to
the amino group of 5P-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-
thioadenosine (SAENTA) with di¡erent spacer arms [7,8].
The £uorescent properties of these compounds make them
suitable for use in £ow cytometric techniques that, to date,
have not yet been applied to the study of the membrane trans-
porters. Flow cytometric studies performed in leukemia cells
and other tumoral models revealed that both 5-(SAENTA-
x2)-£uorescein and 5-(SAENTA-x8)-£uorescein speci¢cally in-
teract with the NBTI-sensitive equilibrative nucleoside trans-
porter (es-nucleoside transporter) [8,9].
In previous works it has been demonstrated that the es-
nucleoside transporters present in neurochroma⁄n cells and
other neural models are regulated by several mechanisms [10].
In this connection, a long-term regulation by thyroid hor-
mones has been demonstrated in rat brain synaptosomes
and in neurochroma⁄n cells [11,12]. In cultured chroma⁄n
cells, the nucleoside transport is also modulated by extracel-
lular signals coupled to the activation of protein kinases A
and C, involving phosphorylation-dephosphorylation proc-
esses [13,14]. In the present work it has been demonstrated
that the es-nucleoside transporters of neurochroma⁄n cells
recognized 5-(SAENTA-x8)-£uorescein with high speci¢city.
Moreover, the £ow cytometric studies that distinguish di¡er-
ent cell types showed that the nucleoside transport inhibition
produced by secretagogues or protein kinase A activation also
modi¢ed the 5-(SAENTA-x8)-£uorescein speci¢c binding to
individual chroma⁄n cells. This ¢nding allows new ap-
proaches to the study of nucleoside transporters in heteroge-
neous populations of neural tissues, which so far have not
been available because of the low number and heterogeneity
of the cells obtained.
2. Materials and methods
2.1. Chroma⁄n cell culture
Primary dissociated adrenomedullary cells were obtained by colla-
genase digestion of bovine adrenal glands and the dissociated cells
were then puri¢ed onto an urogra¢n density gradient [15,16]. The
purity of the cell cultures was routinely assayed by neutral red dye
staining [17] and about 95^99% of them contained catecholamine
cells. Finally, the cells were suspended in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% heat inactivated fetal calf
serum containing 10 WM cytosine arabinofuranoside, 10 WM £uoro-
deoxyuridine and antibiotics (penicillin 5 U/ml, streptomycin 5 mg/ml,
kanamycin 100 Wg/ml and amphotericin 2.5 Wg/ml). The cells were
plated in 24-well Costar dishes pretreated with collagen in order to
make the cells more adherent and maintained at 37‡C in a 5% CO2/
95% air humidi¢ed atmosphere.
The medium was routinely removed and replaced by Locke’s sol-
ution (composition in mM: NaCl 140, KCl 4.4, CaCl2 2.5, MgSO4
1.2, KH2PO4 1.2, EDTA 0.01, HEPES 10 and glucose 5.5; pH 7.4) 1^
2 h before the experiments were carried out.
For £ow cytometry experiments the cells were kept in suspension at
4‡C and used the following day.
2.2. Adenosine transport experiments
Cells plated at a density of 250 000 cells/well were washed in
Locke’s solution for 2 h and [3H]adenosine transport was measured
during the ¢rst minute of incubation at 37‡C as previously described
[13].
For inhibition studies of adenosine transport, the cells were ¢rst
preincubated for 10 min at 37‡C with graded concentrations of 5-
(SAENTA-x8)-£uorescein (0.1^100 nM) and [3H]adenosine transport
was then measured in the presence of this compound.
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2.3. [3H]Nitrobenzylthioinosine binding experiments and
its displacement by 5-(SAENTA-x8)-£uorescein
For binding studies the cultured chroma⁄n cells were plated at a
density of 800 000^106 cells/well and washed with Locke’s solution for
2 h prior to the binding experiments. The maximum number of
[3H]NBTI binding sites per cell was determined by equilibrium bind-
ing analysis as previously described [14]. For displacement studies the
cells were incubated for 20 min at 37‡C with the required concentra-
tion of [3H]NBTI in the presence of graded concentrations of 5-
(SAENTA-x8)-£uorescein.
In another set of experiments, [3H]NBTI equilibrium binding was
carried out with chroma⁄n cells maintained in suspension, in order to
quantify the number of [3H]NBTI binding sites in the same conditions
as the £ow cytometry binding studies. The cell suspension was centri-
fuged and washed, and the cells were ¢nally resuspended in Locke’s
solution at a density of 2U106 cells/200 Wl. The [3H]NBTI binding
was initiated by the addition of 200 Wl of a graded concentration of
labeled ligand and incubated for 30 min at room temperature. After
the incubation time, 100 Wl of ice cold 50 WM NBTI in Locke’s
solution was added to each tube. The cells were then centrifuged at
15 000 rpm for 10 min. The supernatant was aspirated, the cell pellets
were dissolved and the radioactivity counted.
The non-speci¢c binding was calculated by the preincubation of the
cells with 10 WM unlabeled NBTI for 10 min and by quantifying the
[3H]NBTI binding sites in the presence of the unlabeled compound.
This component was routinely subtracted from the total to obtain the
speci¢c binding.
The binding experiments were routinely carried out in the presence
of adenosine deaminase (1 U/ml), to check the presence of extracel-
lular adenosine released from the cells.
2.4. Flow cytometry binding studies
The cell suspension was centrifuged, washed twice in Locke’s sol-
ution and ¢nally resuspended at a density of 106 cells/ml. Chroma⁄n
cells (106 cells) were incubated with a range of 5-(SAENTA-x8)-£uo-
rescein concentrations between 0 and 100 nM at room temperature
(25‡C) for 10 min and the binding of the ligand was analyzed by £ow
cytometry.
Flow cytometry analysis was carried out using a FACScan £ow
cytometer (Becton-Dickinson, San JoseŁ, CA). 10 000 cells were ac-
quired per sample and £uorescence from 5-(SAENTA-x8)-£uorescein
was measured as molecules of equivalent soluble £uorochromes
(MESF), after analysis of £uorescence mean with Quantum 24
(FCS, Leiden) and QuickCal software (FCS, Leiden) following the
manufacturer’s instructions. Brie£y, Quantum 24 is a kit that contains
a set of calibrated £uorescent standards matching the emission and
excitation spectra of 5-(SAENTA-x8)-£uorescein. It is used in the
quanti¢cation of £uorescence intensities between 2000 and 50 000
MESF. In order to quantify £uorescence using a £ow cytometer,
the peak or mean channel must be expressed as relative channel num-
ber (RCN). The QuickCal program performs that conversion and
linear regression to construct calibration plots.
During the cytometric analysis, propidium iodide was used
(0.005%) in PBS medium in all samples to discriminate dead cells
and neutral red staining to identify chroma⁄n cells.
In order to determine the speci¢c binding of the £uorescent ligand
to the nucleoside transporter, the cells were preincubated for 10 min
with 10 WM of NBTI or dilazep, previous to the incubations with
di¡erent concentrations of 5-(SAENTA-x8)-£uorescein.
In another set of experiments the cells were stimulated with several
e¡ectors previous to the incubations with the £uorescent ligand.
2.5. Data analysis
Most experiments were performed in quadruplicate. Values are
means þ S.D. of n experiments.
3. Results
3.1. E¡ect of 5-(SAENTA-x8)-£uorescein on nucleoside trans-
porter
The adenosine transport in chroma⁄n cells was e⁄ciently
inhibited by 5-(SAENTA-x8)-£uorescein as shown in Fig. 1A.
The speci¢c transport was completely abolished at 100 nM
concentration. The mean IC50 value calculated from the in-
hibition curves at 1 WM adenosine concentration was
2.063 þ 0.25 nM (n = 4), indicating a high a⁄nity of this £uo-
rescent ligand for the nucleoside transporter.
In order to assess the speci¢city of 5-(SAENTA-x8)-£uores-
cein to the es-nucleoside transporter of chroma⁄n cells, we
studied whether 5-(SAENTA-x8)-£uorescein was able to dis-
place the binding of the most speci¢c ligand, nitrobenzyl-
thioinosine. Fig. 1B shows the displacement curve obtained
at 1 nM [3H]NBTI by increasing concentrations of the £uo-
rescent compound. Similar displacement curve pro¢les were
obtained at di¡erent [3H]NBTI concentrations (0.5^10 nM)
and the IC50 values calculated ranged from 4 to 15 nM. These
IC50 values gave a ¢rst estimation of the Ki of 4.08 þ 1.3 nM
(n = 4). However, the [3H]NBTI speci¢c binding to chroma⁄n
cells was not completely inhibited by the highest concentra-
tions of the £uorescent ligand used in these experiments (1
WM). This component represented about 12^20% of the total
speci¢c binding and was evident in all the displacement
curves. The analysis of Harris and Winzor [18] was applied
for the [3H]NBTI binding studies (Fig. 2). Brie£y, this analysis
uses all binding data obtained over a range of inhibitor con-
centrations and produces a linear plot in the case of competi-
tion between two ligands for one class of acceptor sites. The
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Fig. 1. A: Dose-dependent inhibition of adenosine transport by 5-
(SAENTA-x8)-£uorescein in cultured chroma⁄n cells. Chroma⁄n
cells were preincubated for 10 min at 37‡C in the presence of
graded concentrations of 5-(SAENTA-x8)-£uorescein (0^100 nM)
and then adenosine transport was measured at 1 WM [3H]adenosine
as described in Section 2. B: Inhibition of [3H]NBTI binding by in-
creasing concentrations of 5-(SAENTA-x8)-£uorescein in cultured
chroma⁄n cells. [3H]NBTI binding was measured for 20 min at
37‡C by incubating the cells in the simultaneous presence of 1 nM
of the labeled ligand and graded concentrations of 5-(SAENTA-x8)-
£uorescein in a range of 0.5^1 WM. Only the speci¢c binding is pre-
sented, calculated as described in Section 2. Values correspond to a
typical experiment of four performed in quadruplicate.
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plot of the data for [3H]NBTI binding to chroma⁄n cells in
the presence of 5-(SAENTA-x8)-£uorescein (Fig. 2) is a curve,
indicating a pool of sites for [3H]NBTI which are inaccessible
to the £uorescent compound. A method of quantitation of
these ‘cryptic’ sites for [3H]NBTI has been established by
Brocklebank et al. [19]. The analysis by this method (data
not shown) predicts a 13% cryptic component (V25 000
sites/cell for 5-(SAENTA-x8)-£uorescein compared to 28 950
sites/cell for [3H]NBTI) and KDW3 nM for 5-(SAENTA-x8)-
£uorescein.
3.2. Flow cytometry analysis of 5-(SAENTA-x8)-£uorescein
binding to chroma⁄n cells
The chroma⁄n cells were incubated in the presence of in-
creasing concentrations of 5-(SAENTA-x8)-£uorescein in the
range of 1^100 nM and the intensity of cell associated £uo-
rescence was measured within 10 min, which is the period in
which equilibrium is reached. As can be seen in the £uores-
cence histograms in Fig. 3, the mean £uorescence intensity
increased with increasing concentrations of 5-(SAENTA-x8)-
£uorescein. The mean channel value obtained at 0 nM of the
£uorescent probe represented the auto£uorescence of chro-
ma⁄n cells, and was routinely subtracted from each mean
£uorescence channel. Due to the high level of auto£uores-
cence in these cells, measurement of cell associated £uores-
cence intensity with 5-(SAENTA-x8)-£uorescein was not pos-
sible below a 1 nM concentration.
The intensity of cell associated £uorescence was consider-
ably reduced when the cells were preincubated in the presence
of the transport inhibitors 1 WM NBTI or dilazep. This rep-
resented the non-speci¢c 5-(SAENTA-x8)-£uorescein binding
and was subtracted from the total component to calculate the
NBTI-sensitive speci¢c binding. The displacement of the £uo-
rescence histograms is shown in Fig. 4.
The mean channel value for each histogram was converted
to MESF using standard £uorescein containing microbeads.
When the speci¢c binding of 5-(SAENTA-x8)-£uorescein in
MESF was plotted against initial ligand concentration, a sat-
uration curve was obtained (Fig. 5), with a half maximal bind-
ing value of 6 þ 1.2 nM (n = 9). The maximal speci¢c binding
was 4400 þ 400 MESF/cell (n = 9).
3.3. Regulatory studies of 5-(SAENTA-x8)-£uorescein binding
by several e¡ectors in chroma⁄n cells
In previous studies we demonstrated that the adenosine
transport in cultured chroma⁄n cells is signi¢cantly inhibited
by stimulation of the cells with secretagogues, such as carba-
chol and DMPP. The [3H]NBTI binding was also a¡ected in
the same fashion. When the cells kept in suspension were
treated with the same secretagogues and the 5-(SAENTA-
x8)-£uorescein binding was analyzed by £ow cytometry, a
signi¢cant reduction in the £uorescence signal was observed,
which was close to 50% inhibition (Fig. 4). Similar results
were obtained when cells were stimulated with forskolin, a
direct activator of adenylate cyclase that is able to increase
intracellular cAMP levels.
4. Discussion
This paper clearly shows that the es-nucleoside transporter
present in neurochroma⁄n cells speci¢cally recognized the
£uorescent ligand, 5-(SAENTA-x8)-£uorescein. The £uores-
cent compound completely inhibited the NBTI-sensitive ad-
enosine transport with high a⁄nity, to the same extent as the
speci¢c inhibitors, NBTI and dilazep. 5-(SAENTA-x8)-£uo-
rescein also displaced the [3H]NBTI binding to the cells, in-
dicating that the two ligands interact with a common site. The
analysis of the equilibrium binding of [3H]NBTI and 5-
(SAENTA-x8)-£uorescein to chroma⁄n cells by the method
of Harris and Winzor [18] shows concave curvilinearity, indi-
cating a component of [3H]NBTI binding that is inaccessible
to 5-(SAENTA-x8)-£uorescein. These ¢ndings are consistent
with studies of the binding of a similar £uorescent ligand, 5-
(SAENTA-x2)-£uorescein, to leukemic RC2A cells [7]. The
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Fig. 3. Fluorescence histograms of 5-(SAENTA-x8)-£uorescein bind-
ing to chroma⁄n cells. Cells were incubated for 10 min at room
temperature with di¡erent concentrations of 5-(SAENTA-x8)-£uo-
rescein from 0 to 100 nM. The cell-bound £uorescence was analyzed
by £ow cytometry as described in Section 2. The £uorescence histo-
gram designated ‘control’ was done at 0 nM of 5-(SAENTA-x8)-£u-
orescein, and represents the cell auto£uorescence. The £uorescence
signals were slightly increased with increasing 5-(SAENTA-x8)-£uo-
rescein concentration and were stabilized at 25^30 nM.
Fig. 2. Analysis of competition between [3H]NBTI and 5-(SAEN-
TA-x8)-£uorescein for sites on chroma⁄n cells by the method of
Harris and Winzor [18]. Total 5-(SAENTA-x8)-£uorescein concen-
trations (CT) used were 5 nM (R), 10 nM (E), 50 nM (F), 100 nM
(a), 500 nM (b) and 1000 nM (U). The intercept (qkSmA) which
should be obtained by linear squares ¢tting in the case of competi-
tive inhibition is shown.
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nature of the ‘cryptic component’ is uncertain. It could rep-
resent either (i) an additional class of sites on the es-nucleo-
side transporter or (ii) an intracellular pool of nucleoside
transporters, assuming that the lipophilic NBTI molecule dif-
fuses across the plasma membrane. Although in chroma⁄n
cells the nucleoside transporters are also located at intracellu-
lar structures, they are not accessible to NBTI binding, ex-
cluding the second possibility. Comparative studies of
[3H]NBTI binding to intact cells or digitonin permeabilized
chroma⁄n cells show the same [3H]NBTI binding sites. Ac-
cess of NBTI to the intracellular binding sites is achieved
when cells are lysed in hypoosmotic medium and the cellular
structure and organelles are destroyed [20,21].
Flow cytometric experiments showed that binding of 5-
(SAENTA-x8)-£uorescein to chroma⁄n cells was inhibited
by NBTI, which con¢rms that the two ligands interact with
a common site. The KD for the binding of 5-(SAENTA-x8)-
£uorescein is similar to [3H]NBTI and that obtained in leu-
kemic RC2a cells [7]. The number of binding sites expressed
as MESF per cell was lower than described in leukemic cells.
Similar di¡erences were obtained in NBTI binding sites for
the two cellular types.
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Fig. 4. Inhibition of 5-(SAENTA-x8)-£uorescein binding by several e¡ectors. Chroma⁄n cells kept in suspension were preincubated for 10 min
at room temperature with 1 WM of the transport inhibitors NBTI and dilazep. Then, the £uorescence probe was added and the cells were fur-
ther incubated for 10 min. The cell-bound £uorescence obtained in these conditions represents the blank value of the £ow cytometric binding
experiments. In another set of experiments, chroma⁄n cells were stimulated at room temperature with 50 WM carbachol and 10 WM DMPP
(data not shown) for 5 min, and with 1 WM forskolin for 10 min. Then, the cell-bound £uorescence intensity was measured for a further 10
min incubation period with 25 nM of 5-(SAENTA-x8)-£uorescein. The di¡erences in the histogram displacement are evidenced by the mean
channel values located in the upper left corner of each panel. These histograms correspond to a typical experiment out of nine performed at 25
nM of 5-(SAENTA-x8)-£uorescein.
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It is well known that the stimulation of chroma⁄n cells
with carbachol, or speci¢c agonists of nicotinic receptors, in-
duces catecholamine secretion with a parallel activation of
protein kinase C [14]. The stimulation of chroma⁄n cells
with forskolin increases intracellular cAMP levels and acti-
vates protein kinase A [13]. In our experimental conditions
forskolin had no e¡ect on catecholamine secretion. It is
clearly shown that chroma⁄n cells stimulated with secreta-
gogues or forskolin exhibited a signi¢cant decrease in speci¢c
5-(SAENTA-x8)-£uorescein binding. This ¢nding in single
chroma⁄n cells correlates well with the [3H]NBTI binding
modi¢cation carried out in chroma⁄n cell populations and
reveals that chroma⁄n cells represent a very homogeneous
cell population with respect to the regulation of nucleoside
transport by these extracellular signals. Moreover, this study
indicates that the £uorescent compound, 5-(SAENTA-x8)-£u-
orescein, is as selective and speci¢c as NBTI not only in leu-
kemic or tumoral cells but also in a neural model, neurochro-
ma⁄n cells. It will allow future approaches to the study of
nucleoside transporter in neural cell preparations. The avail-
ability of speci¢c £uorescent ligands for nucleoside transport-
ers, together with speci¢c markers for di¡erent neuronal
types, can provide new methods for studying the distribution
and possible regulation of nucleoside transporters in the nerv-
ous system.
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Fig. 5. Scatchard representation of the 5-(SAENTA-x8)-£uorescein
binding to chroma⁄n cells. The mean channel values of the £uores-
cence histograms obtained at each 5-(SAENTA-x8)-£uorescein con-
centration were corrected for cell auto£uorescence and then con-
verted to MESF as described in Section 2. Blank values were
obtained in the presence of 1 WM of NBTI or dilazep and were sub-
tracted from the total and only the NBTI-sensitive 5-(SAENTA-x8)-
£uorescein speci¢c binding is represented. Values correspond to a
representative experiment out of nine.
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